EVOLUTION AT MERCK - INVENTING FOR LIFE slide image

EVOLUTION AT MERCK - INVENTING FOR LIFE

ONCOLOGY: DRIVING GLOBAL LEADERSHIP KEYTRUDA (pembrolizumab) Injection 100 mg Lynparza B olaparib tablets 150 mg Foundational cancer treatment 27 Indications LENVIMA (lenvatinib) capsules 10 mg and 4 mg 15 Tumor types + MSI-H Market-leading Broad-based PARPI TKI >200K Patients treated Strong foundation with long runway for growth ahead INVENTING FOR LIFE MERCK # Frank Clyburn 19
View entire presentation